New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Heatwurx Inc. (PCSA) vs Skye Bioscience, Inc. (SKYE)
- Heatwurx Inc. PCSA 1.67 −1.76%
- Skye Bioscience, Inc. SKYE 0.80 −22.33%
Heatwurx Inc. and Skye Bioscience, Inc. are both Biotechnology companies. Heatwurx Inc. and Skye Bioscience, Inc. are of similar size ($4.8M and $4.6M). Across the 10 metrics below, Heatwurx Inc. leads on 6 and Skye Bioscience, Inc. on 4.
Valuation
Profitability
| Metric | PCSA | SKYE | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 68.04% | 70.18% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | 220.06% | (220.31%) | (51.58%) |
| Return on assets | (203.76%) | (162.38%) | (45.91%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack